Food & functionAnimalsGastrointestinal MicrobiomeNon-alcoholic Fatty Liver DiseaseMiceMale
Aglycin ameliorates nonalcoholic fatty liver disease through modulation of the gut microbiota, restoration of the intestinal barrier, and inhibition of hepatic inflammation in mice.
Leyan Zhou, Juan Li, Wei Wei, Xiaomin Ma, Zhuyan Xu, Limin Ouyang, Yutong Guan, Xue Jia, Qiming Wu, Min Zhao
Published: 202510.1039/d5fo03751d
Abstract
The gut microbiota plays a pivotal role in the pathogenesis of metabolic disorders such as nonalcoholic fatty liver disease (NAFLD). Aglycin, a bioactive peptide derived from soybeans, exhibits efficacy in ameliorating various metabolic disorders inc…
Preview only. Read the full abstract at the source